Follow
Lang Li
Title
Cited by
Cited by
Year
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment
Y Jin, Z Desta, V Stearns, B Ward, H Ho, KH Lee, T Skaar, AM Storniolo, ...
Journal of the National Cancer Institute 97 (1), 30-39, 2005
11522005
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment
S Borges, Z Desta, L Li, TC Skaar, BA Ward, A Nguyen, Y Jin, ...
Clinical Pharmacology & Therapeutics 80 (1), 61-74, 2006
5682006
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer
NL Henry, F Azzouz, Z Desta, L Li, AT Nguyen, S Lemler, J Hayden, ...
Journal of Clinical Oncology 30 (9), 936, 2012
3792012
Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate
R Arora, MO Koch, JN Eble, TM Ulbright, L Li, L Cheng
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
3442004
Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant
M Fan, PS Yan, C Hartman-Frey, L Chen, H Paik, SL Oyer, JD Salisbury, ...
Cancer research 66 (24), 11954-11966, 2006
2822006
Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro
Z Desta, T Saussele, B Ward, J Blievernicht, L Li, K Klein, DA Flockhart, ...
Future Medicine Ltd 8 (6), 547-558, 2007
2592007
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
NL Henry, JT Giles, D Ang, M Mohan, D Dadabhoy, J Robarge, J Hayden, ...
Breast cancer research and treatment 111, 365-372, 2008
2582008
Target identification among known drugs by deep learning from heterogeneous networks
X Zeng, S Zhu, W Lu, Z Liu, J Huang, Y Zhou, J Fang, Y Huang, H Guo, ...
Chemical Science 11 (7), 1775-1797, 2020
2332020
Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans
Z Wang, SD Hall, JF Maya, L Li, A Asghar, JC Gorski
British journal of clinical pharmacology 55 (1), 77-85, 2003
2302003
Nuclear factor-κB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate
C Sweeney, L Li, R Shanmugam, P Bhat-Nakshatri, V Jayaprakasan, ...
Clinical Cancer Research 10 (16), 5501-5507, 2004
2162004
Patterns and severity of vincristine‐induced peripheral neuropathy in children with acute lymphoblastic leukemia
EM Lavoie Smith, L Li, CW Chiang, K Thomas, RJ Hutchinson, EM Wells, ...
Journal of the Peripheral Nervous System 20 (1), 37-46, 2015
1912015
A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum‐resistant, epithelial ovarian cancer
F Fang, C Balch, J Schilder, T Breen, S Zhang, C Shen, L Li, ...
Cancer 116 (17), 4043-4053, 2010
1862010
Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells
YC Lim, L Li, Z Desta, Q Zhao, JM Rae, DA Flockhart, TC Skaar
Journal of Pharmacology and Experimental Therapeutics 318 (2), 503-512, 2006
1802006
Prognostic DNA methylation biomarkers in ovarian cancer
SH Wei, C Balch, HH Paik, YS Kim, RL Baldwin, S Liyanarachchi, L Li, ...
Clinical Cancer Research 12 (9), 2788-2794, 2006
1712006
Association of polymorphisms of angiogenesis genes with breast cancer
BP Schneider, M Radovich, GW Sledge, JD Robarge, L Li, AM Storniolo, ...
Breast cancer research and treatment 111, 157-163, 2008
1632008
Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients
S Borges, Z Desta, Y Jin, A Faouzi, JD Robarge, S Philip, A Nguyen, ...
The Journal of Clinical Pharmacology 50 (4), 450-458, 2010
1312010
Genome-wide association studies for taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199
BP Schneider, L Li, M Radovich, F Shen, KD Miller, DA Flockhart, G Jiang, ...
Clinical Cancer Research 21 (22), 5082-5091, 2015
1292015
Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions
JD Duke, X Han, Z Wang, A Subhadarshini, SD Karnik, X Li, SD Hall, ...
Public Library of Science 8 (8), e1002614, 2012
1272012
Variability of heart rate correction methods for the QT interval
M Desai, L Li, Z Desta, M Malik, D Flockhart
British journal of clinical pharmacology 55 (6), 511-517, 2003
1242003
Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase
AI Molosh, PL Johnson, JP Spence, D Arendt, LM Federici, C Bernabe, ...
Nature neuroscience 17 (11), 1583-1590, 2014
1212014
The system can't perform the operation now. Try again later.
Articles 1–20